April 9, 2026

4:30-6PM

Reception 6-7PM

Koch Institute Luria Auditorium, MIT

A decade shaping the future of cancer nanomedicine at MIT

Since 2016, the Marble Center has been tackling grand challenges in cancer detection, treatment and monitoring. Join us as we celebrate Center research, highlight successes, and preview developments guiding the future of cancer nanomedicine.

Speakers include Marble Center Director Sangeeta Bhatia and Koch Institute Director Matthew Vander Heiden, Center member Bob Langer, and a panel of Center alumni and collaborators bringing nanomedicine applications to patients.

Reception to follow (6-7pm)

Agenda

4:30 pm Welcome and introductory remarks (Sangeeta Bhatia, MD, PhD)

4:45 pm A review of nanomedicine (Robert Langer, ScD)

5:00pm Panel on translational nanomedicine

Susan Hockfield, PhD

Moderator, President Emerita, MIT, Professor of Neuroscience

Viktor Adalsteinsson. PhD

Co-founder, Amplifyer Bio; Director, Gerstner Center for Cancer Diagnostics at the Broad Institute of MIT and Harvard

Peter DeMuth, PhD

Chief Scientific Officer, Elicio Therapeutics

Vadim Dudkin, PhD

Founding Chief Technology Officer, Soufflé Therapeutics

Noor Jailkhani, PhD

CEO, Co-founder & President, Matrisome Bio

5:45pm Closing remarks (Matthew Vander Heiden, MD, PhD)

6:00pm Networking reception

7:00pm Event ends

Sangeeta Bhatia (Director, Marble Center for Cancer Nanomedicine, MIT)

Matthew Vander Heiden (Director, Koch Institute, MIT)

Paula Hammond (MIT)

Tarek Fadel (Associate Director, Marble Center for Cancer Nanomedicine, MIT)

Directions to venue

The Koch Institute is located at 500 Main Street between Ames Street and Vassar Street, two blocks from the Kendall/MIT subway station on the MBTA red line at the edge northern edge of the MIT campus in Cambridge. Parking in the area is limited and surrounding roads are prone to construction. We encourage you leave extra travel time when planning your trip.